Literature DB >> 10706807

The population impact of MRSA in a country: the national survey of MRSA in Wales, 1997.

M Morgan1, D Evans-Williams, R Salmon, I Hosein, D N Looker, A Howard.   

Abstract

Continuous data collection on all new isolates of MRSA via CoSurv has taken place in Wales since January 1996. In order to audit this data collection, and to address some of the issues that it does not include, a survey of MRSA was carried out. Questionnaires were completed by infection control teams. Rates were calculated using hospital throughput denominators. Results from the one-day prevalence survey, the two-week incidence survey, and the follow-up survey carried out on new MRSA patients identified in the incidence survey, are presented. Results were found to be broadly similar to those collected via routine surveillance. MRSA was found frequently and disproportionately in the elderly, with higher rates in male than female patients. The highest incidence of total and invasive MRSA was in males aged 75 and over (total: 12.5/1000 finished consultant episodes; invasive: 2.8/1000). Although there was a large community reservoir of MRSA, most appeared to have been acquired in hospital, since most patients had a history of hospitalization, often with multiple hospital admissions. Community-based isolates from cases with no hospital history tended to have been from ulcers. Prevalence and incidence of MRSA was relatively low compared with hospital throughput (mean prevalence: 2.4/100 occupied beds; mean incidence: 3.6/1000 finished consultant episodes), there was also quite large variation between sites, even when screening samples were removed. Patients with MRSA had strikingly long stays before isolation of the organism (prevalence survey: 39 days; incidence survey: 31 days) and highest incidence occurred in elderly care wards. The outcome survey showed that approximately half of the patients were treated with some type of antimicrobial therapy for MRSA. Decontamination therapy was associated with clearance of MRSA only when controlling for sex of the patient. The majority of patients were discharged still with MRSA, mostly to their own homes. The survey emphasizes the need to continue surveillance to detect any changes, to allow guidelines based on evidence to be developed and to monitor the effectiveness of such guidelines. Copyright 2000 The Hospital Infection SocietyCopyright 2000 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2000        PMID: 10706807     DOI: 10.1053/jhin.1999.0695

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study.

Authors:  D Carnicer-Pont; K A Bailey; B W Mason; A M Walker; M R Evans; R L Salmon
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

2.  Population pharmacokinetic and pharmacodynamic modeling of norvancomycin.

Authors:  J Zhang; Y Zhang; Y Shi; J Rui; J Yu; G Cao; J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

3.  A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients.

Authors:  John Seal; Loretto Glynn; Mindy Statter; Donald Liu
Journal:  Pediatr Surg Int       Date:  2006-07-08       Impact factor: 1.827

4.  Investigating the relation between resistance pattern and type of Staphylococcal cassette chromosome mec (SCCmec) in methicillin-resistant Staphylococcus aureus.

Authors:  Christiana Rezk Bottros Youssef; Ashraf Ahmed Kadry; Amira Mohammed El-Ganiny
Journal:  Iran J Microbiol       Date:  2022-02

5.  Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996-1999.

Authors:  Susan S Huang; Brian J Labus; Michael C Samuel; Dairian T Wan; Arthur L Reingold
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

6.  Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002.

Authors:  Edine W Tiemersma; Stef L A M Bronzwaer; Outi Lyytikäinen; John E Degener; Paul Schrijnemakers; Nienke Bruinsma; Jos Monen; Wolfgang Witte; Hajo Grundman
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

7.  A study of the efficacy and cost-effectiveness of MRSA screening and monitoring on surgical wards using a new, rapid molecular test (EMMS).

Authors:  Katherine J Hardy; Ala Szczepura; Ruth Davies; Andrew Bradbury; Nigel Stallard; Savita Gossain; Paul Walley; Peter M Hawkey
Journal:  BMC Health Serv Res       Date:  2007-10-03       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.